Tarsus Pharmaceuticals TARS
$73.01 −$4.66 (-6.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $71.00 -2.75%
Open$77.09
Prev close$77.67
Day range$72.57 – $78.11
Volume706.8K
Market cap$3.60B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$105.57+44.6% vs. price
- Buy 100%
Low $97.00Now $73.01Avg $105.57High $116.00
Recent rating changes
The last 20 actions on file set price targets from $84.00 to $116.00, averaging $101.83.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 11 Nov 2026 | Barclays | BUY | $110.00 |
| 6 Nov 2026 | Mizuho Securities | BUY | $102.00 |
| 4 Nov 2026 | BofA Securities | BUY | – |
| 4 Nov 2026 | Guggenheim | BUY | $97.00 |
| 4 Nov 2026 | H.C. Wainwright | BUY | $106.00 |
| 4 Nov 2026 | Oppenheimer | BUY | $103.00 |
| 29 Oct 2026 | Mizuho Securities | BUY | $94.00 |
| 12 Oct 2026 | BofA Securities | BUY | $84.00 |
| 9 Oct 2026 | Barclays | BUY | $110.00 |
| 2 Oct 2026 | Oppenheimer | BUY | $100.00 |
| 24 Sep 2026 | Goldman Sachs | BUY | $116.00 |
| 16 Sep 2026 | Barclays | BUY | $110.00 |
| 8 Sep 2026 | Jefferies | BUY | $105.00 |
| 12 Aug 2026 | William Blair | BUY | – |
| 12 Aug 2026 | Oppenheimer | BUY | $100.00 |
| 11 Aug 2026 | Mizuho Securities | BUY | $100.00 |
| 8 Aug 2026 | LifeSci Capital | BUY | $104.00 |
| 7 Aug 2026 | LifeSci Capital | BUY | $104.00 |
| 7 Aug 2026 | Mizuho Securities | BUY | $100.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $88.00 |
No comments yet — be the first to weigh in on TARS.
Sign in to join the discussion.